3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Carcinoma, Renal Cell
31
Neoplasms
18
Kidney Neoplasms
17
Neuroendocrine Tumors
16
Neoplasm Metastasis
13
Tuberous Sclerosis
10
Prostatic Neoplasms
8
Carcinoma
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Hodgkin Disease
7
Glioma
7
Glioblastoma
7
Astrocytoma
7
Waldenstrom Macroglobulinemia
6
Triple Negative Breast Neoplasms
6
Recurrence
6
Lymphoma
6
Head and Neck Neoplasms
6
Stomach Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Neuroendocrine
5
Brain Neoplasms
5
Sezary Syndrome
4
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Mycosis Fungoides
4
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Everolimus
×
Clear all
No trials found.